Unlock instant, AI-driven research and patent intelligence for your innovation.

Quinoline compounds and their preparation methods and applications

A compound, technology of dihydroquinoline, applied in the field of medicine

Active Publication Date: 2015-09-02
上海懿峰生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, research on small molecule inhibitors targeting VEGF receptors has been very active, and a large number of inhibitors with different structures have been reported, but there are still some problems with these inhibitors, for example, they are all competitive inhibitors of ATP, and The ATP concentration in cells, especially in cancer cells, can reach more than 5 mmol / L, so the inhibitor activity should reach at least nanomolar level to show effective inhibitory effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quinoline compounds and their preparation methods and applications
  • Quinoline compounds and their preparation methods and applications
  • Quinoline compounds and their preparation methods and applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Preparation of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinoline (Ⅱ)

[0079] Add 22.5g (100.6mmol) of 4-chloro-6,7-dimethoxyquinoline, 15g (100.5mmol) of 6-hydroxy-1,2,3,4-tetrahydroquinoline into a 250ml round bottom bottle, N -Methylpyrrolidone (NMP) 100ml, stir evenly to dissolve, add 33.9g (301.8mmol) of potassium tert-butylate three times under ice bath, heat to 100°C, stir for about 16 hours, follow the reaction by TLC (the developer is petroleum Ether: ethyl acetate = 2.5:2.5), after the reaction is completed, carry out post-processing. NMP was evaporated under reduced pressure, and the residue was washed with water to obtain a pale yellow solid, which was recrystallized from methanol-petroleum ether, filtered, and dried to obtain 19 g of pure product. Yield: 56.2%.

[0080] 1 HNMR(600MHz,DMSO)δ8.43(d,J=5.2Hz,1H),7.49(s,1H),7.36(s,1H),6.77(d,J=2.7Hz,1H),6.76(s, 1H),6.53(d,J=8.2Hz,1H),6.40(d,J=5.2Hz,1H),5.74(s,1H),3.94(s,3H),3.93(s,3H),3.22- 3.19(m...

Embodiment 2

[0081] Embodiment 2 (synthesis of KL-01)

[0082] Add 0.5g (1.5mmol) of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinoline and 10ml of chloroform into a 100ml round bottom bottle, dissolve and keep at room temperature Stir, and take another 0.47g (3.0mmol) of tert-octyl isocyanate in 2ml of chloroform until dissolved, slowly add it to the round bottom bottle after dissolving, react at room temperature for 1 hour, follow the reaction by TLC (developing agent is dichloromethane: methanol =4.5:0.5), reacted at room temperature for 70 hours, and post-treated.

[0083] The reaction solution was transferred to a separatory funnel, 10ml of water was added to the chloroform layer and shaken and washed twice, the chloroform layer was washed once with 5ml of saturated sodium bicarbonate solution, and 10ml of water was added to shake and washed twice, and the chloroform layer was washed with anhydrous magnesium sulfate 1.5 g was dried for 1 hour, filtered, and evaporated to dry...

Embodiment 3

[0085] Embodiment 3 (synthesis of KL-02)

[0086]Add 0.5g (1.5mmol) of 6,7-dimethoxy-4-(1,2,3,4-tetrahydroquinoline-6oxy)quinoline and 10ml of chloroform into a 100ml round bottom bottle, dissolve and keep at room temperature Stir, and take another 0.44g (3.0mmol) of 2-ethylphenyl isocyanate in 2ml of chloroform until dissolved, slowly add it to the round bottom bottle after dissolving, react at room temperature for 1 hour, follow the reaction by TLC (the developer is ethyl acetate Ester:methanol=4.7:0.3), react at room temperature for 65 hours, and post-treatment.

[0087] The reaction solution was transferred to a separatory funnel, 10ml of water was added to the chloroform layer and shaken and washed twice, the chloroform layer was washed once with 5ml of saturated sodium bicarbonate solution, and 10ml of water was added to shake and washed twice, and the chloroform layer was washed with anhydrous magnesium sulfate 1.5 g was dried for 1 hour, filtered, and evaporated to dr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, in particular to a quinoline tyrosine kinase inhibitor as well as a preparation and an application of the quinoline tyrosine kinase inhibitor in preparation of antineoplastic drugs. The structure formula (I) of a compound is as follows: the compound has good tyrosine kinase inhibitory activity, particularly, VEGFR2 and VEGFR3 inhibitory activities, and partial compound is subjected to liver microsome metabolic rate study, absorption characteristic study in a Caco-2 model and drug metabolism kinetic study.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a class of quinoline tyrosine kinase inhibitors, a preparation method thereof and an application in preparation of antitumor drugs. Background technique [0002] Malignant tumors are one of the major diseases that seriously affect human health and threaten human life. Both the World Health Organization and government health departments of various countries have listed cancer as a top priority. At present, the anticancer drugs commonly used in clinical practice are mainly cytotoxic drugs. Due to the inherent nature of cytotoxicity, these drugs have unavoidable disadvantages such as poor selectivity, strong side effects, and easy drug resistance. Therefore, finding new targets with high specificity, low toxicity, and good patient tolerance has become an urgent need for anticancer drug research. In recent years, with the rapid development of life science research, many specific ta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D215/233C07D405/14A61K31/4709A61P35/00A61P35/02
CPCC07D215/233C07D405/14
Inventor 不公告发明人
Owner 上海懿峰生物科技有限公司